Overview

Perfenidone in Type 2 Diabetic Patients With Diabetic Neuropathy

Status:
COMPLETED
Trial end date:
2025-03-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness \& safety of pirfenidone in type 2 diabetic patients with diabetic nephropathy
Phase:
PHASE4
Details
Lead Sponsor:
Sidrah Lodhi
Treatments:
pirfenidone